4Raskin P, Gylvin T, Weng W ,et al. Comparison of insulin de temir and insulin glargine using a basal-bolus regimen in a randomized,controlled clinical study in patients with type 2 diabetes. Diabetes Metab Res Rev,2009,25:542-548.
5Russell-Jones D. Blood Glucose and Bodyweight in Type 2 Diabetes -Are These Compatible Treatment Targets? Eur Endocrinol, 2008, 4(2):31-34.
6Wildman RP, Gu D, Reynolds K, et al. Are waist circumference and body massindex independently associated with cardiovascular disease risk in Chinese adults? Am J Clin Nutr, 2005, 82:185-202.
8Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coil Nutr, 2003,22:331-339.
9Williamson DF, Thompson TJ, Thun M, et al. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care, 2000,23:1499-1504.
10Effect of intensive blood-glucose control with mefformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 1998,352:854-865.
二级参考文献33
1The Diabetes Control and Complications Research Group. Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care, 1995,18 : 1415-1427.
2UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998,352: 837 -853.
3Yki-Jarvinen H, Ryysy L, Kauppila M, et al. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1997,82 : 4037-4043.
4DCCT Research Group. Weight gain associated with intensive therapy in the diabetes control and complications trial. Diabetes Care, 1988,11 : 567-573.
5Lin X, Taguchi A,Park S, et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and dia betes. J Clin Invest,2004,114:908-916.
6Brunner GA, Sendhofer G, Wutte A, et al. Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans. Exp Clin Endocrinol Diabetes, 2000,108 : 100-105.
7Havelund S, Ribel U, Plum A, et al. The mechanism of protraction of insulin detemir, a long acting, acylated analogue of human insulin. Diabetes, 2004,53 : P462.
8Hermansen K, Fontaine P, Kukolja KK, et al. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insu lins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia, 2004,47 : 622-629.
9Raslovd K, Bogoev M, Raz I,et al. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract, 2004,66:193-201.
10Haak T, Tiengo A, Draeger E,et al. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab, 2005,7 : 56-64.
2Leslie W S,Hankey C R,Lean M E J.Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QJM : monthly journal of the Association of Physicians . 2007
3Domecq JP,Prutsky G,Leppin A,et al.Drugs commonly associated with weight change:A systematic review and meta-analysis. The Journal of Clinical Endocrinology . 2015
4JW Anderson,FL Greenway,K Fujioka,KM Gadde,J McKenney,PM O’Neil.Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. Obesity Research . 2002
5George A. Bray,Donna H. Ryan.??Medical Therapy for the Patient With Obesity(J)Circulation . 2012 (13)
6Joseph C. Ratliff,Jessica A. Barber,Laura B. Palmese,Erin L. Reutenauer,Cenk Tek.Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey. Obesity . 2010
7Fava M,Judge R,Hoog S L,Nilsson M E,Koke S C.Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. The Journal of clinical psychiatry . 2000
